Jazz Pharmaceuticals Announces Third Quarter 2022 Financial Results and Raises Total Revenue Guidance Mid-point
Go back to Jazz Pharmaceuticals Announces Third Quarter 2022 Financial Results and Raises Total Revenue Guidance Mid-point| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 241.46 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $241.46 | 52 Week High | $160.00 | |||
| Open | $241.46 | 52 Week Low | $95.80 | |||
| Day High | $241.46 | P/E | 44.88 | |||
| Day Low | $241.46 | EPS | $5.38 | |||
| Volume | 2,678 | |||||
